Rocket Pharma adopts severance program; new CEO/GC/COO employment agreements

ROCKET PHARMACEUTICALS, INC.

CEO Gaurav Shah gets $674,856 base salary, 60% target bonus; 15-month severance (non-CIC) and 18-month (CIC).
GC Martin Wilson gets $547,313 base salary, 45% target bonus; 12-month severance, plus 12-month CIC terms.
COO Christopher Stevens amendment: 12-month base salary severance, CIC terms include target bonus and prorated bonus.
New severance program covers all eligible US employees; CEO gets 15/18 months, ELT 12 months, VPs 6/9 months, etc.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.